Showing results (161-170 of 443) with videos related to

Sort By:
Pageof 45
Cancer|September 20, 2011
Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantationMin Fang, Barry Storer, Brent Wood, et al.
British Journal of Haematology|April 22, 2005
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantationMarco Mielcarek, Lauri Burroughs, Wendy Leisenring, et al.
Blood|October 4, 2003
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioningWolfgang A Bethge, Ute Hegenbart, Monic J Stuart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphomaAndrew R Rezvani, Barry Storer, Michael Maris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2016
Steroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized TrialsArmin Rashidi, John F DiPersio, Brenda M Sandmaier, et al.
Cancer Chemotherapy and Pharmacology|August 3, 2013
A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipientsMeagan J Bemer, Mohamed Sorror, Brenda M Sandmaier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2018
Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation PatientsJeannine S McCune, Barry Storer, Sushma Thomas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosingMichael B Maris, Brenda M Sandmaier, Barry E Storer, et al.
ILAR Journal|March 19, 2009
Gene therapy in large animal models of muscular dystrophyZejing Wang, Jeffrey S Chamberlain, Stephen J Tapscott, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogsMaura H Parker, Christian Kuhr, Stephen J Tapscott, et al.
Pageof 45